Stratification based on AML-BFM protocols was as follows: patients with RUNX1::RUNX1T1, CBFB::MYH11, PML::RARA, normal karyotype with NPM1, or biallelic CEBPA mutations were categorized in the favorable subgroup. The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.